Detailed information for compound 1830044

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 614.685 | Formula: C35H38N2O8
  • H donors: 1 H acceptors: 3 LogP: 4.27 Rotable bonds: 15
    Rule of 5 violations (Lipinski): 2
  • SMILES: O=C([C@@H](NC(=O)[C@@H]1CCCN1C(=O)OCc1ccccc1)Cc1ccccc1)O[C@@H]1CO[C@H]2[C@@H]1OC[C@H]2OCc1ccccc1
  • InChi: 1S/C35H38N2O8/c38-33(28-17-10-18-37(28)35(40)44-21-26-15-8-3-9-16-26)36-27(19-24-11-4-1-5-12-24)34(39)45-30-23-43-31-29(22-42-32(30)31)41-20-25-13-6-2-7-14-25/h1-9,11-16,27-32H,10,17-23H2,(H,36,38)/t27-,28-,29+,30+,31+,32+/m0/s1
  • InChiKey: VBOBVMMYZHORIY-VQKSECAYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens kallikrein-related peptidase 7 Starlite/ChEMBL References
Homo sapiens kallikrein-related peptidase 5 Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Brugia malayi Trypsin family protein kallikrein-related peptidase 7 181 aa 186 aa 32.8 %
Echinococcus granulosus subfamily S1A unassigned peptidase S01 family kallikrein-related peptidase 5 293 aa 290 aa 26.6 %
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Echinococcus multilocularis alpha 1,6 mannosyl glycoprotein 1.9463 1 0.5
Toxoplasma gondii dgat2l1-prov protein 0.0287 0 0.5
Trypanosoma brucei diacylglycerol acyltransferase, putative 0.0287 0 0.5
Echinococcus granulosus alpha 16 mannosyl glycoprotein 1.9463 1 0.5
Loa Loa (eye worm) hypothetical protein 1.9463 1 1
Trypanosoma cruzi diacylglycerol acyltransferase, putative 0.0287 0 0.5
Schistosoma mansoni beta-12-n-acetylglucosaminyltransferase II 1.9463 1 1
Trypanosoma cruzi diacylglycerol acyltransferase, putative 0.0287 0 0.5
Onchocerca volvulus 0.0287 0 0.5
Leishmania major diacylglycerol acyltransferase, putative 0.0287 0 0.5

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 3.9 uM Inhibition of human recombinant KLK5 expressed in baculovirus-infected insect cell system using Abz-KLRSSKQ-Eddnp as substrate incubated for 5 mins prior to substrate addition by FRET assay ChEMBL. 24900785
IC50 (binding) = 19.6 uM Inhibition of human recombinant KLK7 expressed in baculovirus-infected insect cell system using Abz-KLYSSKQ-Eddnp as substrate incubated for 5 mins prior to substrate addition by FRET assay ChEMBL. 24900785
Inhibition (binding) Inhibition of human KLK6 at 1 to 500 uM after 5 mins by spectrophotometry ChEMBL. 24900785
Inhibition (binding) Inhibition of human KLK1 at 1 to 500 uM after 5 mins by spectrophotometry ChEMBL. 24900785
Ki (binding) = 0.4 uM Competitive inhibition of human recombinant KLK5 expressed in baculovirus-infected insect cell system using Abz-KLRSSKQ-Eddnp as substrate incubated for 5 mins prior to substrate addition by Lineweaver-Burk plot analysis ChEMBL. 24900785
Ki (binding) = 2.8 uM Competitive inhibition of human recombinant KLK7 expressed in baculovirus-infected insect cell system using Abz-KLYSSKQ-Eddnp as substrate incubated for 5 mins prior to substrate addition by Lineweaver-Burk plot analysis ChEMBL. 24900785

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.